NC
NEO icon

NinePointTwo Capital’s NeoGenomics NEO Stock Holding History

NinePointTwo Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$253K Hold
15,683
– – 0.1% 178
2023
Q3 		$192K Sell
15,683
-545
-3% -$8.1K 0.08% 221
2023
Q2 		$260K Buy
+16,228
New +$267K 0.1% 103

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

NinePointTwo Capital's NEO Position: Q4 2023 in Review

NinePointTwo Capital held its NeoGenomics (NEO) position steady in Q4 2023 at 15,683 shares worth $253K. The position accounts for 0.1% of the portfolio, ranked #178.

NinePointTwo Capital first reported a position in NEO in Q2 2023 and has held it in 3 quarters since. The position peaked at $260K in Q2 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • NinePointTwo Capital held 15,683 shares of NeoGenomics worth $253K as of Q4 2023.
  • NinePointTwo Capital left its NeoGenomics share count unchanged in Q4 2023.
  • NeoGenomics made up 0.1% of NinePointTwo Capital's portfolio in Q4 2023, its #178 holding.
  • NinePointTwo Capital first reported a position in NeoGenomics in Q2 2023 and has held it in 3 quarters since.
  • NinePointTwo Capital's NeoGenomics position peaked at $260K in Q2 2023.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.